Anti-AQP6/ AQP2L/ KID monoclonal antibody

Anti-AQP6/ AQP2L/ KID antibody for FACS & in-vivo assay

Target products collectionGo to AQP6/AQP6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0082-Ab-1/ GM-Tg-hg-MP0082-Ab-2Anti-Human AQP6 monoclonal antibodyHuman
GM-Tg-rg-MP0082-Ab-1/ GM-Tg-rg-MP0082-Ab-2Anti-Rat AQP6 monoclonal antibodyRat
GM-Tg-mg-MP0082-Ab-1/ GM-Tg-mg-MP0082-Ab-2Anti-Mouse AQP6 monoclonal antibodyMouse
GM-Tg-cynog-MP0082-Ab-1/ GM-Tg-cynog-MP0082-Ab-2Anti-Cynomolgus/ Rhesus macaque AQP6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0082-Ab-1/ GM-Tg-felg-MP0082-Ab-2Anti-Feline AQP6 monoclonal antibodyFeline
GM-Tg-cang-MP0082-Ab-1/ GM-Tg-cang-MP0082-Ab-2Anti-Canine AQP6 monoclonal antibodyCanine
GM-Tg-bovg-MP0082-Ab-1/ GM-Tg-bovg-MP0082-Ab-2Anti-Bovine AQP6 monoclonal antibodyBovine
GM-Tg-equg-MP0082-Ab-1/ GM-Tg-equg-MP0082-Ab-2Anti-Equine AQP6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0082-Ab-1/ GM-Tg-hg-MP0082-Ab-2; GM-Tg-rg-MP0082-Ab-1/ GM-Tg-rg-MP0082-Ab-2;
GM-Tg-mg-MP0082-Ab-1/ GM-Tg-mg-MP0082-Ab-2; GM-Tg-cynog-MP0082-Ab-1/ GM-Tg-cynog-MP0082-Ab-2;
GM-Tg-felg-MP0082-Ab-1/ GM-Tg-felg-MP0082-Ab-2; GM-Tg-cang-MP0082-Ab-1/ GM-Tg-cang-MP0082-Ab-2;
GM-Tg-bovg-MP0082-Ab-1/ GM-Tg-bovg-MP0082-Ab-2; GM-Tg-equg-MP0082-Ab-1/ GM-Tg-equg-MP0082-Ab-2
Products NameAnti-AQP6 monoclonal antibody
Formatmab
Target NameAQP6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-AQP6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species AQP6/ AQP2L/ KID VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP004738human KID Lentivirus plasmid
    ORF Viral VectorvGMLP004738human KID Lentivirus particle


    Target information

    Target IDGM-MP0082
    Target NameAQP6
    Gene ID363,11831,29170,711968,607978,101093446,527759,100629869
    Gene Symbol and SynonymsAQP2L,AQP6,KID
    Uniprot AccessionQ13520,Q9WTY0
    Uniprot Entry NameAQP6_HUMAN,AQP6_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000086159
    Target ClassificationN/A

    The target: AQP6, gene name: AQP6, also named as AQP2L, KID. The protein encoded by this gene is an aquaporin protein, which functions as a water channel in cells. Aquaporins are a family of small integral membrane proteins related to the major intrinsic protein (MIP or AQP0). This protein is specific for the kidney. This gene and related family members AQP0, AQP2, and AQP5 reside in a cluster on chromosome 12q13. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.